Darrel Gumm, MD, Vice President, OSF HealthCare Cardiovascular Institute
Episode 46: The Power of Personalized Medicine
Your family history could hold critical clues about your health. By combining cutting-edge technology with genetic research, OSF Innovation is empowering physicians with information that fosters a more personalized approach to care, potentially saving lives.
Join us as we explore how OSF Innovation is leveraging artificial intelligence (AI) to analyze medical records and identify individuals who may be at risk for familial hypercholesterolemia (FH). Often undiagnosed, FH is a genetic condition that causes dangerously high levels of LDL cholesterol, increasing the risk of heart disease, heart attacks and strokes, even in younger adults. For people with FH, early detection is key to preventing life-threatening complications.
Host Shelli Dankoff chats with Darrel Gumm, MD, vice president of OSF HealthCare Cardiovascular Institute, and Ryan Loudermilk, a strategic program manager in Performance Improvement at OSF Innovation about how AI-driven insights are transforming the way FH is detected and managed. Learn how this innovative approach to personalized medicine is making heart health more proactive and precise than ever before.
Listen on your preferred platform:
Accelerate the Delivery of Care
Do you have interest in transforming the future of care with us? Contact us today and start the process.
Connect with UsFeatured on this Episode
Ryan Loudermilk, Strategic Program Manager, Performance Improvement, OSF Innovation